Similar articles

• Asthma-chronic obstructive pulmonary disease overlap syndrome in the urban Chinese population: prevalence and disease burden using the 2010, 2012, and 2013 China National Health and Wellness Surveys.

  Ding B, DiBonaventura M, Karlsson N, Ling X. Ding B, et al. Int J Chron Obstruct Pulmon Dis. 2016 Jun 9;11:1139-50. doi: 10.2147/COPD.S103873. eCollection 2016. Int J Chron Obstruct Pulmon Dis. 2016. PMID: 27354777 Free PMC article.
• The direct and indirect costs of managing chronic obstructive pulmonary disease in Greece.

  Souliotis K, Kousoulakou H, Hillas G, Tzanakis N, Toumbis M, Vassilakopoulos T. Souliotis K, et al. Int J Chron Obstruct Pulmon Dis. 2017 May 10;12:1395-1400. doi: 10.2147/COPD.S132825. eCollection 2017. Int J Chron Obstruct Pulmon Dis. 2017. PMID: 28546747 Free PMC article.
• COPD symptom burden: impact on health care resource utilization, and work and activity impairment.

  Ding B, Small M, Bergström G, Holmgren U. Ding B, et al. Int J Chron Obstruct Pulmon Dis. 2017 Feb 21;12:677-689. doi: 10.2147/COPD.S123896. eCollection 2017. Int J Chron Obstruct Pulmon Dis. 2017. PMID: 28260874 Free PMC article.
• [COPD: Burden, risk factors and prevalence].

  Karpinski NA, Petermann F. Karpinski NA, et al. Gesundheitswesen. 2009 Dec;71(12):816-22. doi: 10.1055/s-0029-1231048. Epub 2009 Jul 20. Gesundheitswesen. 2009. PMID: 19621281 Review. German.
• Socioeconomic burden of immune-mediated inflammatory diseases--focusing on work productivity and disability.

  Jacobs P, Bissonnette R, Guenther LC. Jacobs P, et al. J Rheumatol Suppl. 2011 Nov;88:55-61. doi: 10.3899/jrheum.110901. J Rheumatol Suppl. 2011. PMID: 22045980 Review.